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Abstract
Cluster-randomized clinical trials (CRT) are trials in which the unit of randomization is not a 
participant but a group (e.g. healthcare systems or community centers). They are suitable when the 
intervention applies naturally to the cluster (e.g. healthcare policy); when lack of independence 
among participants may occur (e.g. nursing home hygiene); or when it is most ethical to apply an 
intervention to all within a group (e.g. school-level immunization). Because participants in the 
same cluster receive the same intervention, CRT may approximate clinical practice, and may 
produce generalizable findings. However, when not properly designed or interpreted, CRT may 
induce biased results.
CRT designs have features that add complexity to statistical estimation and inference. Chief 
among these is the cluster-level correlation in response measurements induced by the 
randomization. A critical consideration is the experimental unit of inference; often it is desirable to 
consider intervention effects at the level of the individual rather than the cluster. Finally, given that 
the number of clusters available may be limited, simple forms of randomization may not achieve 
balance between intervention and control arms at either the cluster- or participant-level.
In non-clustered clinical trials, balance of key factors may be easier to achieve because the sample 
can be homogenous by exclusion of participants with multiple chronic conditions (MCC). CRTs, 
which are often pragmatic, may eschew such restrictions. Failure to account for imbalance may 
induce bias and reducing validity. This article focuses on the complexities of randomization in the 
design of CRTs, such as the inclusion of patients with MCC, and imbalances in covariate factors 
across clusters.
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 INTRODUCTION
The US Department of Health and Human Services has made addressing clinical trials of 
people with multiple chronic conditions (MCC) a priority [1]. People with MCC take 
multiple medications, which are rarely tested together in a randomized clinical trial. In fact, 
these individuals are often excluded from trials as a matter of course in order to decrease 
potential sources of variation and bias.
Thus, trials in this area may not be generalizable to the most important clinical populations. 
This is a major concern; for results to be applicable to clinical practice, it is essential that an 
intervention is effective in the true target population, not only in idealized samples. 
Accordingly, recent guidance has emphasized [2] “the FDA’s interest in encouraging a broad 
population sample in the development of new drugs.”
A key first step in trial design is determining how best to randomize participants. The 
balance among arms of observed and unobserved factors is a goal of randomization for 
unbiased estimation of intervention effects. Cluster randomized trials (CRT) – in which the 
unit of randomization is a group of participants [3,4], or “cluster” – are relevant for 
interventions applied at the level of the group, and may offer some advantages in trials 
enrolling participants with MCC. There are substantial difficulties introduced by clustered 
sampling of participants, stemming largely from the correlation between individuals enrolled 
within a cluster [5]. Here we provide a brief overview of randomization in CRTs, discuss the 
pros and cons of these designs for complex patient populations, and propose a direction for 
future methodological development in this area.
 THE ROLE OF RANDOMIZATION
We rely upon randomization to achieve comparable treatment and control arms, balanced on 
both measured and unmeasured factors, so that the difference between them can be given a 
causal interpretation [6,7]. While the benefits of simple randomization follow readily when 
the number of randomized units is large (e.g. the number of participants in a large, non-
clustered trial), they may not hold when the number of randomized units is small. In a CRT, 
the unit of randomization is the cluster, and these may be few in number. In this situation, 
there is a much greater probability of not achieving balance between trial arms under simple 
randomization schemes, compromising the validity of the trial results. Therefore, 
refinements on more simple methods of randomization are often necessary. There has been 
substantial attention to the problem of obtaining balance on covariates at the time of 
randomization, but numerous difficulties persist [8].
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 BALANCING CLUSTERS IN RANDOMIZED DESIGNS
When deciding on the best way to randomize clusters to ensure balance across treatment 
arms, we must first decide whether the unit of inference will be the cluster or rather the 
participant [9]. In the former case, simple methods may be used to compare, for instance, the 
mean rate of change on some outcome in treatment clusters versus control clusters, and for 
each cluster the outcomes data are reduced to the average rate of change for that cluster. 
Covariates are likewise applicable to the cluster itself and are taken to apply to it as a whole. 
Under this paradigm, comparability of treatment and control units randomized is equivalent 
to comparability of cluster-level factors; these should in principle be balanced by even 
simple randomization of clusters, though in practice the number of clusters is often too few 
to insure this.
When the unit of inference is the individual, by contrast, it is necessary that one be able to 
estimate the difference between comparable individuals assigned to treatment and to control. 
Comparability at the level of the individual, however, is not directly addressed by simple 
randomization of clusters to treatment and control. Imbalance among important 
characteristics may cause confounding of treatment and prognostic factors and adversely 
affect the interpretation and finding of the trial [10]. This may be further complicated by 
design elements – for instance, in situations where one is interested in a subset of individuals 
within each cluster, due to trial exclusions or limits on enrollment. If not all patients from a 
cluster are enrolled and those patients enrolled do not reflect the aggregate characteristics of 
the cluster, there could be severe imbalances at the level of the individual. This is especially 
applicable for trials with patients with MCC, who may often be excluded from participation 
and/or be unevenly distributed among geographic regions, hence across randomized clusters. 
Typically, trial designers do not have the necessary composite cluster-level characteristics or 
individual-level characteristics available for study until after participant enrollment and 
cluster randomization has occurred. Therefore, trial designers must rely on data from 
secondary sources. If these data are available, methods may be deployed to assist in 
balancing on these factors, but rely on the applicability of these data to the current trial 
population.
 SIMULTANEOUS VS. SEQUENTIAL RANDOMIZATION SCHEMES
Randomization methods can broadly be divided into simultaneous and sequential schemes. 
A summary of some of the most common methods available is presented in Table 1; each 
has its own advantages and disadvantages. In simultaneous randomization, the full sampling 
frame is created and all clusters are randomized prior to enrollment of participants. This 
approach is easier to operationalize as the randomized units can begin preparations and 
participant enrollments at the same time. They have as a limitation, however, the fact that 
they cannot be modified after the fact. Several methods of restricted or constrained 
randomization, simultaneous approaches, have been proposed to achieve overall balance in 
trials, especially when a small number of units (i.e. participants or clusters) are being 
randomized. For example, in one trial of ten universities in North Carolina a matching 
process was used before randomization to achieve balance between the schools in the two 
arms [11].
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In sequential randomization, clusters are randomized over time as they are included in the 
study. This approach, though more difficult to implement, in principle allows for 
consideration of balance as an evolving state that can be monitored and controlled via 
randomization as the trial proceeds. Adaptive randomization – in which features of the 
design are changed or updated in response to the current state of enrollment – can be 
considered an important subset of sequential schemes, but few adaptive cluster 
randomization methods have been described in the literature.
As difficulty in enrolling enough participants is a key hurdle in randomized trials, an 
important challenge in maintaining the balance between arms after the initial randomization 
occurs when clusters need to be added, typically to meet recruitment goals. Randomization 
methods that allocate units in a sequential manner (e.g. baseline covariate adaptive 
randomization [10,12]) allow for the addition of participants later in the trial, but require 
flexibility on the part of investigators and trial centers. If investigators cannot stagger 
enrollment across centers or they do not have a large enough pool of clusters, these methods 
still may not be practical. In simultaneous schemes (e.g. covariate constrained 
randomization) [13,14], there is no defined method to include additional clusters once the 
initial randomization is completed. As noted above, these methods must rely on what limited 
data is available on key risk factors and/or only cluster level information is available at the 
time of study start. Given the desire to include participants with MCC and to conduct more 
pragmatic trials with diverse populations, there is a need to expand upon these methods to 
insure valid results.
 MULTIFACTORIAL INTERVENTIONS
CRTs can be advantageous for testing multiple-component interventions tailored to an 
individual’s risk factors, designs that we refer to as standardly-tailored. For example, an 
intervention may combine protein and vitamin D supplementation, where only participants 
below a certain daily intake of protein are considered for randomization to the former, and 
only those whose circulating vitamin D levels are below a certain threshold are considered 
for randomization to the latter. The standardly-tailored intervention allows participants to be 
enrolled in the trial as long as they have at least one of the risk factors. Participants 
randomized to intervention receive those components relevant to their status (in the example 
above, either protein or vitamin D supplementation or both), while those not randomized to 
intervention receive a placebo, standard care, or some other control regime. These designs 
are thus highly applicable to trials enrolling individuals with MCC.
A CRT of a standardly-tailored multi-component intervention produces a distribution of 
interventions and components with marked similarities to clinical practice in that, within 
clusters randomized to interventions, participants receive those components appropriate to 
their health state. Thus, standardly-tailored designs are highly pragmatic and may produce 
more immediately applicable findings. They also present sizable methodological challenges. 
In addition to the issues related to randomization described above, analyses of these designs 
must acknowledge that individuals may not be eligible or need every component of the 
intervention given their risk factor profile. In CRTs, this treatment (and corresponding risk 
factor) heterogeneity may exacerbate the complex imbalances that can occurs between 
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clusters, as well as inducing different treatment effects among subpopulations of 
participants, which may in turn be unevenly spread across clusters.
 LIMITATIONS OF CLUSTER RANDOMIZED TRIAL DESIGNS
While CRTs are advantageous and may closely represent clinical practice, they also present 
substantial challenges. With the movement toward inclusion of more complex patient 
populations and to more pragmatic clinical trials, the limits of the currently methodology 
will be tested, and refinements will prove necessary. However, the shift from CRT to 
pragmatic trials that may use cluster randomization often include a generalizable population 
and potentially many clusters, with few if any techniques available for balancing covariates. 
Trial designers should weight the tradeoffs of enrolling few large clusters (often fewer than 
100), or many smaller clusters, which may be protected by randomization.
To date there is no established method describing the addition or replacement of a cluster 
following the use of matching or any of the simultaneous randomization schemes, such as 
covariate constrained randomization. The flexibility needed for large scale CRTs to meet the 
realities of the healthcare systems, clinical practices, and patient populations in which they 
are used makes some randomization procedures infeasible, while casting doubt on the 
applicability of others. As the call for pragmatic trials strengthens, there may be more 
emphasis to use trials that are broadly inclusive of people with MCC and other complex 
populations.
 CHALLENGES TO DEVELOPING CRT AMONG POPULATIONS WITH MCC
The overarching methodologic challenges inherent in CRT designs [9,15–17] may be 
exacerbated by the demands of the specific patient population under study and inattention to 
best practices. Numerous authors have described the difficulties in developing and reporting 
CRT in primary care [18–20], cardiovascular health [21], nutrition [22], pediatrics [23], pain 
management [24], and other fields [25,26]. Even identifying published reports of CRT in a 
specific area can be difficult [27], and the quality of reporting of critical information may be 
lacking. A recent review estimated that fewer than one quarter of publications describing 
CRT provide tabular depictions of covariate data; only 17% of trials reporting the use of 
covariates in randomization adjusted for all of those covariates in analysis [28]. For 
populations with MCC, the reporting of illnesses, multimorbidity and other potential 
confounders is an obvious concern. Though few adaptive CRT have been published, a recent 
report describes difficulties common to all trials but of particular relevance to cluster 
designs, including a need to make unplanned revisions to the randomization scheme due to 
practical limitations on enrollment and retention [24]; it seems likely that cluster trials 
among participants with MCC would face similar challenges. More rigorous methods and 
enhanced guidance addressing these difficulties are needed.
 CONCLUSION
CRTs offer considerable benefits in that they allow for the testing of complex interventions 
intended to produce change at the group level, and the manner in which they deploy 
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interventions is somewhat more reminiscent of clinical practice than is the case in 
conventional randomized trials. However, there are substantial methodological costs accrued 
in deploying cluster designs. The issue of imbalance on confounders is a critical concern that 
is not addressed in simple randomization schemes. Methods for insuring balance can be 
deployed under simultaneous or sequential matching schemes, but these rely heavily on 
existing or accumulated data applicable to the trial population. If the unit of analysis is the 
participant, these difficulties can be substantially exacerbated. The benefits and weaknesses 
of the various approaches described in Table 1 should be carefully taken into account during 
the design of a CRT. Additionally, with increasing emphasis on pragmatic trials, as well as 
the inclusion of individuals with complex disease states, future expansion and refinement of 
these methods is of urgent importance.
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Table 1
Description of Competing Randomization Procedures for Cluster Designs
Randomization Procedure Description Advantages Disadvantages
Simple Randomization
Unrestricted technique, based on 
single sequence random 
assignment. All allocations of units 
randomized are possible.
Simple and easy to 
implement. Balances 
covariates with large 
sample sizes.
Subjects enrolled may not have 
balance on covariates when the 
sample size is moderate or small.
Stratified Randomization
Restricted technique: Create a 
stratum for each combination of 
covariates being considered. Units 
are then randomly assigned to 
treatment arms within each stratum.
Reduces imbalance 
between treatment 
groups on important 
covariates. Able to 
control and balance 
covariates of 
importance.
Limited number of factors can 
be stratified on, and need to be 
willing to categorize continuous 
variables. Number of strata 
needed increases rapidly as the 
number of covariates increases.
Matching
Restricted technique: Select from a 
smaller set of all possible 
allocations, those fulfilling certain 
restrictions (i.e. meet the matching 
criteria), and then randomly 
allocate to the treatment arms 
within each match.
Reduces imbalance 
between treatment 
groups on important 
covariates. Able to 
control and balance 
covariates of 
importance.
Need to identify pairs of clusters 
that are well-matched on all of 
the risk factors, which is often 
not feasible, especially when 
subsets of people are enrolled in 
each cluster post-randomization. 
Need to set suitable balance 
criteria.
Covariate Constrained Randomization
Restricted technique: Find the 
number of allocations meeting a set 
of balancing criteria for the 
covariates of interest. Ensure that 
overly constrained designs do not 
exist (e.g. same clusters always 
appearing in same group) – 
otherwise need to adjust balance 
criteria. Randomly select one 
allocation for the study.
Can attain balance (or 
near balance) on 
covariates related to 
outcome resulting in a 
gain in efficiency. Do 
not need to categorize 
covariates.
Need to set suitable balance 
criteria. If balance criteria are 
too restricted, it could result in 
biased or invalid design. 
Performed at the start of trial, so 
infeasible when need to add 
more clusters.
Minimal Sufficient Balance [29]
Restricted technique: Distribution 
of covariates between treatment 
arms assessed using imbalance 
tests, and depending on results 
units are assigned treatment based 
on biased coin or simple random 
assignment
Prevents serious 
imbalance on important 
covariates, while 
maintaining 
randomness of 
treatment allocation. Do 
not need to categorize 
covariates.
Expected that units are being 
randomized sequentially. Could 
be deterministic. Need to set 
suitable balance criteria.
Minimization [10]
Restricted technique: Sequentially 
assign units to treatment groups 
taking into account the balance on 
covariates and previous 
randomization assignments.
Maintains balance 
among several 
covariates, while 
minimizing imbalance 
in the distribution of the 
treatment across whole 
trial and each 
stratification variable.
Expectation is that units being 
randomized are available 
sequentially, which is usually not 
the case in a cluster-randomized 
trial. Could have imbalance in 
specific strata. Criticized for 
being too deterministic.
Dynamic Randomization [12]
Restricted technique: For each level 
of a stratification hierarchy, a 
balance criteria is set, to keep 
imbalances from exceeding these 
limits. If imbalance is within limits 
for all levels, unit is randomly 
assigned, otherwise allocation is 
forced at stratification level where 
limits exceeded to reduce 
imbalance.
Maintains balance on 
treatment assignments 
across the whole trial 
and within each strata. 
Most useful in 
unblinded trials.
Need a centrally administered 
trial. Expected that units are 
being randomized sequentially.
Outcome Adaptive Randomization 
[30]
Restricted technique: Class of 
methods including those proposed 
by Bather, [31] Thompson, [32] 
Zelen, [33] Sobel and Weiss, [34] 
and Berry and Fristedt, [35] in 
which treatment assignment is 
Objective is to 
maximize the number 
of overall successes, 
maximize effective 
treatment.
Expected that units are being 
randomized sequentially. Need 
real time reporting of outcomes 
that can be measured shortly 
after treatment initiation, (e.g. 
pain relief for a treatment).
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Randomization Procedure Description Advantages Disadvantages
dependent on response of previous 
individuals.
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